BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Factor Ixa

Below is an extended Factor Ixa research listing. Click here to return to the Factor Ixa main in depth entry.

Recent Publications on Factor Ixa:

Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
Protein S functions as an activated protein C (APC)-independent...
Direct Link
2nd September, 2008
Department of Paediatrics, Nara Medical University, Kashihara, Nara,
Effects of apoptosis and lipid peroxidation on T-lymphoblastoid phospholipid-dependent procoagulant activity.
BACKGROUND: Coagulation has an absolute requirement for macromolecular...
Direct Link
14th August, 2008
Biotherapeutics Group, National Institute for Biological Standards and
Protamine inhibits formation of the covalent factor IXa-anti-thrombin complex.
The effect of protamine sulfate upon the covalent interaction of human...
Direct Link
8th August, 2008
Department of Chemistry, Bowling Green State University, Bowling Green,
Influence of nanometric holes on the sensitivity of a waveguide-mode sensor: label-free nanosensor for the analysis of RNA aptamer-ligand interactions.
Evanescent-field-coupled (EFC) waveguide-mode sensors can be used to...
Direct Link
5th August, 2008
Center for Applied Near Field Optics Research (CAN-FOR), National
The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.
The role of the factor IXa heparin-binding exosite in coagulation was...
Direct Link
24th July, 2008
Dept. of Medicine, University of Wisconsin-Madison, Madison, Wisconsin,
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.
BACKGROUND: Whether selective factor IXa inhibition produces an...
Direct Link
24th July, 2008
Duke Clinical Research Institute, 2400 Pratt St, Terrace Level Room 0311,
Characterization of an ideal amphipathic peptide as a procoagulant agent.
On the basis of previous evidence that amphipathic helical peptides...
Direct Link
17th July, 2008
Lady Davis Institute for Medical Research, Jewish General Hospital, McGill
A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor.
BACKGROUND: Active and safe reversibility of anticoagulation is an unmet...
Direct Link
9th July, 2008
Duke Clinical Research Institute, Durham, NC 27705, USA.
Identification of a plasmin-interactive site within the A2 domain of the factor VIII heavy chain.
Factor VIII is activated and inactivated by plasmin by limited...
Direct Link
3rd July, 2008
Department of Pediatrics, Nara Medical University, Kashihara, Nara
Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development.
In mild/moderate haemophilia A (MHA) patients, many factor VIII (FVIII)...
Direct Link
25th June, 2008
Centre de traitement pour Hemophiles AP-HP Hopital Bicetre, Universite
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study.
BACKGROUND: Inhibitors of factor (F) IXa show potent antithrombotic...
Direct Link
18th June, 2008
Sahlgrenska University Hospital/Ostra, Goteborg, Sweden.
Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex.
Factor VIII is a procofactor that plays a critical role in blood...
Direct Link
17th June, 2008
Marine Biological Laboratory, Woods Hole, MA 02543, USA.
Identification of 31 novel mutations in the F8 gene in Spanish hemophilia A patients: structural analysis of 20 missense mutations suggests new intermolecular binding sites.
Hemophilia A (HA) is an X-linked bleeding disorder caused by a wide...
Direct Link
16th May, 2008
Department of Genetics and Centro de Investigacion Biomedica en Red de
Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies.
BACKGROUND: Factor VIIIa (FVIIIa) binds to activated FIX and enhances the...
Direct Link
2nd May, 2008
Baxter BioScience, Department of Discovery Research and Technical
Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite.
Ixolaris is a two-Kunitz tick salivary gland tissue factor pathway...
Direct Link
7th March, 2008
Instituto de Bioquimica Medica, Centro de Ciencias de Saude, Universidade
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional